Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Lotemax (Loteprednol) Etabonate Ophthalmic Suspension)
Company:  Bausch & Lomb
Application No.:  20-841
Approval Date: 3/9/1998


Date created: April 04, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.